Special Feature Innovation New Opportunities in Regenerative Medicine & Cell Therapy In its third Mid-term Business Plan (the 3rd MTBP), Sumitomo Dainippon Pharma points to

Source URL: www.ds-pharma.com

• Cell biology
• Cell therapy
• Ranirestat
• Sumitomo Chemical
• Sunovion
• Embryonic stem cell
• Methamphetamine
• Zonisamide
• Cancer stem cell
• Biology
• Stem cells
• Biotechnology